⌘K
Loading ticker…
As of 2026-08-21, Gilead Sciences Inc (GILD) has a 3-month relative strength percentile of 70 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 53. The current market Stance is 49.9 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 2.9%, relative volume 0.80×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
GILD is held by 124 ETFs as of May 2026. Top owner: QQQM at 0.73% weight, $709M notional. Top 3 carry $1.4B.
Held by 444 ETFs · $33.4B across latest filings · largest weight 14.63% (BBH).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| QQQMInvesco NASDAQ 100 ETF | 0.73% | $709M | −0.26 pp |
| VHTVanguard Health Care ETF | 2.64% | $501M | −0.10 pp |
| SCHXSchwab U.S. Large-Cap ETF | 0.24% | $177M | −0.05 pp |
| AVLVAvantis U.S. Large Cap Value ETF | 1.29% | $165M | −0.49 pp |
| SPMOInvesco S&P 500 Momentum ETF | 0.83% | $164M | −0.58 pp |
| MGV | 0.80% | $102M | −0.12 pp |
| SCHBSchwab U.S. Broad Market ETF | 0.23% | $99M | −0.05 pp |
| TQQQProShares UltraPro QQQ | 0.22% | $88M | −0.36 pp |
| SCHVSchwab U.S. Large-Cap Value ETF | 0.54% | $84M | −0.08 pp |
| FNDXSchwab Fundamental U.S. Large Company Index ETF | 0.32% | $81M | −0.08 pp |
Showing 10 of 124 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Attention is elevated versus its own recent norm without the relative strength to match — the loud-but-lagging pattern. Worth a skeptical eye; not a short signal.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | GILD Jan avg: 3.82% median: 1.50% win: 50% σ: 8.77% n: 4 2022-04-12 → 2026-07-31 | GILD Feb avg: 2.65% median: 0.43% win: 50% σ: 11.32% n: 4 2022-04-12 → 2026-07-31 | GILD Mar avg: -0.95% median: -0.19% win: 50% σ: 4.22% n: 4 2022-04-12 → 2026-07-31 | GILD Apr avg: -5.41% median: -4.92% win: 0% σ: 3.67% n: 5 2022-04-12 → 2026-07-31 | GILD May avg: 1.50% median: 2.74% win: 60% σ: 5.84% n: 5 2022-04-12 → 2026-07-31 | GILD Jun avg: -0.61% median: 0.17% win: 60% σ: 5.06% n: 5 2022-04-12 → 2026-07-31 | GILD Jul avg: 2.13% median: 1.28% win: 60% σ: 5.45% n: 5 2022-04-12 → 2026-07-31 | GILD Aug avg: 2.79% median: 2.23% win: 100% σ: 2.78% n: 4 2022-04-12 → 2026-07-31 (current) | GILD Sep avg: -0.11% median: -1.88% win: 25% σ: 4.18% n: 4 2022-04-12 → 2026-07-31 | GILD Oct avg: 11.46% median: 6.93% win: 100% σ: 10.56% n: 4 2022-04-12 → 2026-07-31 | GILD Nov avg: 4.69% median: 4.64% win: 75% σ: 5.89% n: 4 2022-04-12 → 2026-07-31 | GILD Dec avg: 0.20% median: -1.24% win: 25% σ: 3.84% n: 4 2022-04-12 → 2026-07-31 |